◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Conavi Medical Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 367,000 63,000 58,000 8.6M 0.00 --
Operating Revenue 367,000 63,000 58,000 8.6M 0.00 --
Cost Of Revenue 33,000 1,000 -87,000 1.5M -- 459,000
Gross Profit 334,000 62,000 145,000 7.1M -- -58,000
Selling General And Administration 1.6M 1.3M 1.5M 1.7M 2.6M --
General And Administrative Expense 1.6M 1.3M 1.5M 1.7M 2.6M --
Research And Development 3.6M 3.2M 3.8M 4.7M -14,862 --
Depreciation And Amortization In Income Statement 200,000 203,000 201,000 209,000 -- 222,000
Other Operating Expenses 16,000 -- -- 232,000 -- --
Operating Expense 5.4M 4.7M 5.6M 6.8M 2.6M --
Operating Income -5.1M -4.6M -5.4M 269,000 -2.6M --
EBIT -6.9M -3.2M -2.8M 3.8M -2.4M --
Interest Expense -74,000 346,000 342,000 10.8M 39,181 --
Interest Expense Non Operating -74,000 346,000 342,000 10.8M 39,181 --
Interest Income 38,000 52,000 10,000 -- 56,745 29,000
Interest Income Non Operating 38,000 52,000 10,000 -- 56,745 29,000
Net Interest Income 213,000 -294,000 -332,000 -10.8M 17,564 --
Other Income Expense -1.9M 1.4M 2.6M 3.5M 114,842 --
Other Non Operating Income Expenses -- -- -- -5.0M -- -2.7M
Special Income Charges 0.00 0.00 0.00 -- 113,491 0.00
Restructuring And Mergern Acquisition -- 0.00 -- -- -- 0.00
Gain On Sale Of Security -1.9M 1.4M 2.6M 8.5M 1,351 --
Pretax Income -6.8M -3.6M -3.1M -7.0M -2.5M --
Tax Provision -- -- -- -- 0.00 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -6.8M -3.6M -3.1M -7.0M -2.5M --
Net Income From Continuing Operation Net Minority Interest -6.8M -3.6M -3.1M -7.0M -2.5M --
Net Income Including Noncontrolling Interests -6.8M -3.6M -3.1M -7.0M -2.5M --
Net Income Common Stockholders -6.8M -3.6M -3.1M -7.0M -2.5M --
Net Income -6.8M -3.6M -3.1M -7.0M -2.5M --
EBITDA -6.7M -3.0M -2.6M 4.0M -2.2M --
Normalized EBITDA -4.7M -4.4M -5.2M -4.5M -2.3M --
Reconciled Depreciation 200,000 203,000 202,000 208,000 240,000 --
Basic EPS -- -0.05 -0.07 -0.18 -0.06 -0.29
Diluted EPS -- -0.05 -0.07 -0.18 -0.06 -0.29
Basic Average Shares -- 68.5M 44.3M 40.1M 44.3M 44.3M
Diluted Average Shares -- 68.5M 44.3M 40.1M 44.3M 44.3M
Total Unusual Items -1.9M 1.4M 2.6M 8.5M 114,842 --
Total Unusual Items Excluding Goodwill -1.9M 1.4M 2.6M 8.5M 114,842 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -4.9M -4.9M -5.7M -15.5M -2.6M --
Depreciation Amortization Depletion Income Statement 200,000 203,000 201,000 209,000 -- 222,000
Diluted NI Availto Com Stockholders -6.8M -3.6M -3.1M -7.0M -2.5M --
Gain On Sale Of Ppe -- -- -- -- 0.00 --
Net Income Continuous Operations -6.8M -3.6M -3.1M -7.0M -2.5M --
Net Non Operating Interest Income Expense 213,000 -294,000 -332,000 -10.8M 17,564 --
Other Gand A 1.6M 1.3M 1.5M 1.7M 2.6M --
Other Special Charges -- -- -- -- -113,491 --
Reconciled Cost Of Revenue 33,000 1,000 -87,000 1.5M -- 459,000
Rent Expense Supplemental -- -- 0.00 106,000 -- --
Total Expenses 5.5M 4.7M 5.5M 8.4M 2.6M --
Total Operating Income As Reported -5.1M -4.6M -5.4M 269,000 -2.6M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 5.8M 11.3M 1.0M 5.1M 4.1M --
Cash Cash Equivalents And Short Term Investments 5.8M 11.3M 1.0M 5.1M 4.1M --
Cash Financial -- -- -- 5.1M 4.1M --
Other Short Term Investments -- -- -- 332,000 -- --
Accounts Receivable 407,000 287,000 246,000 549,000 -- --
Receivables 672,000 2.0M 1.1M 1.7M 179,694 --
Inventory 341,000 131,000 137,000 103,000 -- --
Prepaid Assets 1.4M -- -- -- 82,416 --
Current Assets 8.3M 13.4M 2.3M 6.9M 4.3M --
Gross PPE 6.5M 6.1M 6.1M 6.2M -- --
Accumulated Depreciation -4.5M -3.9M -3.9M -3.8M -- --
Net PPE 2.0M 2.1M 2.3M 2.4M -- --
Goodwill And Other Intangible Assets 2.2M 2.1M 2.2M 2.2M -- --
Other Intangible Assets 2.2M 2.1M 2.2M 2.2M -- --
Other Non Current Assets -- -- 27,000 52,000 -- --
Total Non Current Assets 4.2M 4.3M 4.5M 4.7M 75,660 --
Total Assets 12.4M 17.7M 6.8M 11.6M 4.4M --
Current Debt 1.1M 687,000 614,000 482,000 -- --
Current Debt And Capital Lease Obligation 1.9M 1.6M 1.4M 1.3M 589,071 --
Accounts Payable 2.9M 3.4M 6.1M 5.0M 848,478 --
Payables 2.9M 3.4M 6.1M 5.0M 1.0M --
Payables And Accrued Expenses 2.9M 3.4M 6.1M 5.0M 1.2M --
Current Accrued Expenses -- -- -- -- 166,183 --
Current Deferred Revenue 606,000 251,000 251,000 135,000 -- --
Other Current Liabilities 2.8M 1.1M 2.2M 5.2M -- --
Current Liabilities 8.2M 6.3M 9.9M 11.6M 2.0M --
Long Term Debt 17.3M 17.6M 17.7M 17.0M -- --
Long Term Debt And Capital Lease Obligation 18.0M 18.4M 19.0M 18.3M 512,059 --
Long Term Capital Lease Obligation 734,000 804,000 1.3M 1.4M 512,059 --
Total Non Current Liabilities Net Minority Interest 22.3M 23.2M 23.9M 23.4M 512,059 --
Total Liabilities Net Minority Interest 30.5M 29.5M 33.8M 35.0M 2.5M --
Common Stock 126.8M 126.7M 114.7M 114.7M 359.5M --
Capital Stock 126.8M 126.7M 114.7M 114.7M 359.5M --
Retained Earnings -167.0M -160.2M -156.6M -153.5M -396.1M --
Gains Losses Not Affecting Retained Earnings 16.1M 15.6M 14.9M 15.3M 34.8M --
Other Equity Adjustments 16.2M 16.5M 16.1M 16.1M 34.8M --
Common Stock Equity -18.0M -11.8M -27.0M -23.4M 1.9M --
Stockholders Equity -18.0M -11.8M -27.0M -23.4M 1.9M --
Total Equity Gross Minority Interest -18.0M -11.8M -27.0M -23.4M 1.9M --
Total Capitalization -763,000 5.8M -9.3M -6.5M 1.9M --
Net Tangible Assets -20.2M -13.9M -29.2M -25.7M 1.9M --
Tangible Book Value -20.2M -13.9M -29.2M -25.7M 1.9M --
Working Capital 58,000 7.1M -7.6M -4.8M 2.4M --
Invested Capital 343,000 6.5M -8.6M -6.0M 1.9M --
Total Debt 19.9M 20.0M 20.3M 19.7M 1.1M --
Net Debt 12.5M 7.0M 17.3M 12.4M -- --
Share Issued 76.8M 76.8M 44.3M 44.3M 44.3M --
Ordinary Shares Number 76.8M 76.8M 44.3M 44.3M 44.3M --
Buildings And Improvements 1.6M 856,000 920,000 -- -- --
Capital Lease Obligations 1.5M 1.7M 2.0M 2.2M 1.1M --
Current Capital Lease Obligation 800,000 932,000 752,000 852,000 589,071 --
Current Deferred Liabilities 606,000 251,000 251,000 135,000 -- --
Finished Goods 0.00 0.00 25,000 28,000 -- --
Foreign Currency Translation Adjustments -163,000 -895,000 -1.1M -726,000 -- --
Income Tax Payable -- -- -- -- 32,426 --
Leases 1.2M 1.2M 1.2M 1.2M -- --
Machinery Furniture Equipment 939,000 927,000 922,000 915,000 -- --
Non Current Accounts Receivable -- -- -- -- 75,660 --
Non Current Deferred Liabilities 4.3M 4.8M 4.9M 5.1M -- --
Non Current Deferred Revenue 4.3M 4.8M 4.9M 5.1M -- --
Other Current Borrowings 1.1M 687,000 614,000 482,000 -- --
Other Equity Interest 6.1M 6.1M -- -- 3.7M --
Other Payable -- -- -- -- 147,268 --
Other Properties 2.9M 3.2M 3.2M 4.1M -- --
Other Receivables -- 1.5M 773,000 806,000 81,065 --
Pensionand Other Post Retirement Benefit Plans Current -- -- -- -- 186,449 --
Preferred Stock 0.00 0.00 0.00 0.00 -- --
Properties 0.00 0.00 0.00 0.00 -- --
Raw Materials 307,000 129,000 110,000 46,000 -- --
Taxes Receivable 265,000 203,000 128,000 332,000 98,629 --
Total Tax Payable -- -- -- -- 32,426 --
Work In Process 34,000 2,000 2,000 29,000 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -5.0M -7.8M -3.6M -8.7M -4.5M --
Cash Flow From Continuing Operating Activities -5.0M -7.8M -3.6M -8.7M -4.5M --
Depreciation And Amortization 200,000 203,000 202,000 208,000 240,000 --
Depreciation Amortization Depletion 200,000 203,000 202,000 208,000 240,000 --
Stock Based Compensation 296,000 66,000 11,000 65,000 66,000 --
Change In Working Capital -644,000 -3.5M 1.7M -1.2M 1.6M --
Changes In Account Receivables 49,000 -14,000 327,000 329,000 -166,000 --
Change In Receivables -14,000 -88,000 531,000 265,000 -231,000 --
Change In Inventory -209,000 5,000 -33,000 1.5M 727,000 --
Change In Payables And Accrued Expense -408,000 -2.7M 1.1M -2.8M 858,000 --
Change In Other Working Capital -- 0.00 -- -- -- --
Other Non Cash Items -10.9M 283,000 279,000 7.7M -1.2M --
Capital Expenditure -100,000 -6,000 -34,000 -43,000 -206,000 --
Purchase Of PPE -11,000 -6,000 -27,000 -29,000 -159,000 --
Net PPE Purchase And Sale -11,000 -6,000 -27,000 -29,000 -159,000 --
Investing Cash Flow -100,000 -6,000 -34,000 3.7M -206,000 --
Cash Flow From Continuing Investing Activities -100,000 -6,000 -34,000 3.7M -206,000 --
Issuance Of Debt 0.00 -- -- -- 3.5M --
Repayment Of Debt -301,000 -428,000 -373,000 -430,000 -170,000 --
Net Issuance Payments Of Debt -301,000 -428,000 -373,000 -430,000 3.4M --
Issuance Of Capital Stock -40,000 12.1M 0.00 10.1M 0.00 --
Net Common Stock Issuance -40,000 12.1M 0.00 10.1M 0.00 --
Financing Cash Flow -363,000 18.0M -373,000 9.7M 3.4M --
Cash Flow From Continuing Financing Activities -363,000 18.0M -373,000 9.7M 3.4M --
Changes In Cash -5.4M 10.2M -4.1M 4.7M -1.3M --
Beginning Cash Position 11.3M 1.0M 5.1M 436,000 1.7M --
End Cash Position 5.8M 11.3M 1.0M 5.1M 436,000 --
Free Cash Flow -5.1M -7.8M -3.7M -8.8M -4.7M --
Amortization Cash Flow 63,000 63,000 63,000 62,000 68,000 --
Amortization Of Intangibles 63,000 63,000 63,000 62,000 68,000 --
Asset Impairment Charge -93,000 0.00 0.00 137,000 89,000 --
Change In Prepaid Assets 103,000 -745,000 32,000 -177,000 -21,000 --
Common Stock Issuance -40,000 12.1M 0.00 10.1M 0.00 --
Depreciation 137,000 140,000 139,000 146,000 172,000 --
Gain Loss On Investment Securities -- -1.2M -2.9M -8.5M -- --
Gain Loss On Sale Of PPE 108,000 1,000 -2,000 95,000 7,000 --
Long Term Debt Payments -301,000 -428,000 -373,000 -430,000 -170,000 --
Net Foreign Currency Exchange Gain Loss 283,000 -14,000 193,000 -201,000 1.4M --
Net Income From Continuing Operations -6.8M -3.6M -3.1M -7.0M -16.1M --
Net Intangibles Purchase And Sale -89,000 0.00 -7,000 -14,000 -47,000 --
Net Long Term Debt Issuance -301,000 -428,000 -373,000 -430,000 -170,000 --
Net Other Investing Changes 0.00 0.00 0.00 3.8M -- --
Net Short Term Debt Issuance 0.00 -- -- -- 3.5M --
Operating Gains Losses 13.0M -1.2M -2.7M -8.6M 1.6M --
Proceeds From Stock Option Exercised -22,000 6.3M -- -- 0.00 --
Purchase Of Intangibles -89,000 0.00 -7,000 -14,000 -47,000 --
Short Term Debt Issuance 0.00 -- -- -- 3.5M --
NEWS
Loading news...
TRENDING
Loading...